Embed Size (px)
Citation preview
FIGO continues its global agendathrough a productive 2017!
In ter nat iona l Federat ion of Gynecology and Obstet r ics | September 2017 1
International Federation ofGynecology and [email protected] September 2017
The FIGO Reproductive Medicine, Endocrinologyand Infertility Committee met in Dublin in earlyMay, which I attended as an ex officio member.The Committee has been doing superb workunder the sterling leadership of Dr EdgarMocanu.
The FIGO Executive Board meeting was held inLondon on 13 May. Detailed discussions onvarious Committees took place and two newones were formed: one on minimal accesssurgery and one on non-communicablediseases, combining the Hyperglycemia inPregnancy and the Adolescent, Pre-conceptionand Maternal Nutrition Working Groups.
Towards the end of May, I attended the 25thEuropean Congress of Obstetrics andGynaecology in Turkey, participating in theinauguration and as a guest speaker.
From there, I went to Geneva for a few days toattend the important WHO World HealthAssembly (WHA) and to represent FIGO. I amabsolutely delighted that Dr Tedros AdhanomGhebreyesus has been elected as the new WHODirector-General. We look forward to workingclosely with him.
In June I went back to Dubai to select the
FIGO takes high profile at ICM Congress in Toronto | IJGO Impact Factor soars | FIGO Misoprostol Dosage Chart – new release! | WOMAN trial: reducing maternal deaths with
tranexamic acid | FIGO Secretariat awarded SILVER by ‘Investors in the Environment’INSIDE:
Dear ColleaguesWith vacation time ending, many of you must bereturning to work after much needed familyholidays! FIGO has been working hard since mylast communication to you.
In preparation for the FIGO Regional Congress inDubai from 11–13 April 2018, I spent three daysin April inspecting various venues and havingmeetings with government authorities to get thevery best support for our event.
I then travelled to London to attend the 1st WorldCongress on Maternal Fetal Neonatal Medicine inLondon, which took place from 23–26 April. continued on page 2
Demonstrating the ‘FIGO Gyn Cancer Management’ app at the 25th Asian & Oceanic Congress of Obstetrics & Gynaecology (AOCOG), Hong Kong (June 2017), with the FIGO Past President,Professor Sir Sabaratnam Arulkumaran (left), and Dr Neerja Bhatla, Chair of the FIGO Committee for Gynecologic Oncology (see next page for app links)
With the newDirector-Generalof WHO, DrTedros AdhanomGhebreyesus, atthe World HealthAssembly,Geneva (May 2017)
FIGO continues its global agenda through a productive 2017!continued from page 1
2
Professional Congress Organiser (PCO) andfinalise the venue for the FIGO RegionalCongress in April 2018, which will be held at theIntercontinental Hotel Convention Centre.
The Asia Oceania Federation conference(AOCOG) was held in Hong Kong in mid-June – Iwas present, and gave an oration on FIGO’s‘Good Practice Recommendations in Obstetrics’.
The following weekend was spent in Pune, India,at ‘FOGSI CNN 2017’, where I spoke on‘Nutrition First.’
A Joint Meeting of FOGSI, RCOG and AICC washeld on 30 June at the RCOG, and I was presentfor the inauguration and activities, ending with acolourful evening!
In early July, I attended the high profile FamilyPlanning Summit in London. One major eventwas the late Dr Babatunde Osotimehin’smemorial lecture, organised by UNFPA and theBill and Melinda Gates Foundation. A newinitiative – ‘She Decides’ – was launched duringthe Summit, a timely global campaign originatedby the Dutch Government, to promote the rightsof girls and women to decide their sexual andreproductive lives.
FIGO Session atAOCOG
Delivering a lecture atthe Royal College ofObstetricians andGynaecologists’ ‘India Day’, London(June 2017)
At the end of July, the 25th Congress of theObstetrical and Gynaecological Society ofMalaysia was held – I attended the inaugurationand gave a plenary keynote address.
In a busy August, I was delighted to attend theSri Lanka College of Obstetricians andGynaecologists’ (SLCOG) Golden Jubileeconference in Colombo. The inauguration wasattended by the President of Sri Lanka andaddressed by the Health Minister, along with thePresidents of FIGO, AOFOG and SAFOG.SLCOG conferred on me the HonoraryFellowship (FSLCOG), which was an honour toFIGO, and I was asked to give a keynoteaddress.
This was quickly followed by the FOGSI-FIGO2017 International Congress on ‘ClinicalChallenges in Obstetrics and Gynaecology’ inHyderabad, where I inaugurated and gave anoration lecture. FIGO had a special session thereand was well represented by Professor GianCarlo Di Renzo, Honorary Secretary, Dr CarlosFüchtner, President Elect, and Mr Johan Vos, ourChief Executive.
The next quarter will be equally busy,
including attendance at the UN GeneralAssembly in September, and I look forward toupdating you on further important activities in theDecember newsletter.
Best wishes
Professor C N PurandareFIGO President2015–2018
PRESIDENT’S MESSAGE
In ter nat iona l Federat ion of Gynecology and Obstet r ics | September 2017
‘FIGO Gyn CancerManagement’ appiphone: https://itunes.apple.com/us/app/figo-gyn-cancer-management/id1153038788?mt=8Android: https://play.google.com/store/apps/details?id=app.com.figostaging&hl=en
At the Committee for Reproductive Medicine, Endocrinology and Infertility meeting, Dublin (May 2017)
Presenting the IS Puvan MemorialLecture at the 25th Congress of theObstetrical &GynaecologicalSociety of Malaysia,Kuala Lumpur (July 2017)
With the EBCOG President, Dr Tahir Mahmood (left), at the 25th European Congress of Obstetrics and Gynecology (May 2017)
With the Hyderabad police commander (centre, in white) and Dr Diana Galimberti, Chairof the FIGO Working Group on Violence Against Women (centre) at the ‘Stop ViolenceAgainst Women’ campaign in Hyderabad (August 2017)
CHIEF EXECUTIVE’S OVERVIEW
In ter nat iona l Federat ion of Gynecology and Obstet r ics | September 2017 3
working collaboratively is the key – no singlecountry, company or NGO can solve globalissues on its own.
FIGO continues to be richly served by the manyexperts that serve on its Committees andWorking Groups. I was pleased to participate in arecent meeting of the Committee for Women’sHealth and Human Rights (WHHR), ably chairedby Professor Chiara Benedetto. The meeting alsoincluded the participation of Dr Diana Galimberti,Chair of the FIGO Working Group on ViolenceAgainst Women. The Officers and I will discusslater this year how we can make theseCommittees and Working Groups more effectiveand offer more support from the FIGO office.
The global agenda for women’s health andwellbeing continues to be extremely busy. This isgood in many ways, but it requires a strong teamthat is fit for purpose. FIGO has embarked on anexciting new direction where we look atredefining our strategic priorities and makingchanges that will make us a strongerorganisation. Changes are happening and we willcontinue to ensure that our Member Societiesand Regional Federations are aligned andappropriately resourced towards a commonpurpose: for women of the world to achieve thehighest possible standards of physical, mental,reproductive and sexual health and wellbeingthroughout their lives.
I invite you to stay in touch with our work byfollowing us on social media(www.facebook.com/FIGO.org and@FIGOHQ). If you are based in London, pleasefeel welcome to come and visit us at FIGOHouse!
Wishing you all the best in your work.
Best wishes
Johan VosFIGO Chief Executive
FIGO House, Waterloo Court, 10 Theed Street, London SE1 8ST, UKTel: +44 20 7928 1166Fax: +44 20 7928 7099Email: [email protected]: www.figo.org
The International Federation of Gynecology andObstetrics is a UK Registered Charity (No 1113263;Company No 5498067) registered in England andWales. The Registered Office is shown above.
Administrative Director:Sean O’Donnell
FIGO Officers:
President:Professor Chittaranjan Narahari Purandare (India)
President-Elect:Dr Carlos Füchtner (Bolivia)
Vice President:Professor Seija Grenman (Finland)
Honorary Secretary:Professor Gian Carlo Di Renzo (Italy)
Honorary Treasurer:Dr Ralph Hale (USA)
Dr Yirgu Gebrehiwot Ferede (Ethiopia)
Chief Executive:Johan Vos
Readers are invited to refer items for consideration byemail to [email protected] no later thanFriday 13 October 2017 for the next issue.
The views expressed in articles in the FIGO Newsletterare those of the authors and do not necessarily reflectthe official viewpoint of FIGO.
Produced and edited by Alexandra Gilpin at the FIGOSecretariat © FIGO 2017.
International Federation of Gynecology and Obstetrics
Dear Colleagues and FriendsI hope this newsletter finds you well and that youenjoy reading some of the highlights from thepast few months.
One of the strategic priorities for FIGO is to be astrong advocate for women’s health globally. Ourvoice is starting to resonate louder as wecontinue to build our presence at major meetingslike the World Health Assembly in Geneva everyMay, and the United Nations’ General Assemblyin New York in September. FIGO is one of theglobal organisations that has consultative statuswith the UN and is in official relations with theWHO. Through these agencies, we work on alarge number of initiatives and also providecomment on the strategies, such as the WHOGlobal Strategy for Women’s, Children’s andAdolescents’ Health (2016–2030). Every countryis mandated to work towards key indicatorswithin the plan, which provides an opportunity towork closer with our Member Societies.Strengthening our advocacy at global, regionaland national levels will enable FIGO to better helpwomen and children.
As the global voice for women’s health, FIGOwas also invited to participate in the FamilyPlanning Summit held in July in London. Thisevent was supported by the UK government andthe Bill and Melinda Gates Foundation. The newWHO Director-General, Dr Tedros AdhanomGhebreyesus, was present, as were many other
Advocacy is key to our mission
leaders and ministers. FIGO was represented byPresident Professor Purandare, Ms Jill Sheffield(Chair, FIGO Working Group on Contraception)and I. One of the initiatives resulting from theGlobal Gag Rule imposed by the US was one ledby the Dutch government called ‘She Decides’(www.shedecides.nl). Launched by LiliannePloumen, Minister for Foreign Trade andDevelopment Cooperation, the main aim is todraw awareness that every woman and girlshould have the right to decide how she lives herlife. FIGO is working to further promote the‘rights-based agenda’ for women, so expect tohear much more on this and other advocacyinitiatives.
Working with our Member Societies and helpingbuild capacity is another key priority for FIGO. Astronger Member Society will ultimately lead tobetter service standards. This will lead to a morerespected and stronger voice to influenceGovernments; it will also yield betteropportunities to influence policy, which will likelyresult in better services for women and childrenin these countries. Working togethercollaboratively is what will make FIGO and itsMember Societies stronger. Equally important isour relationship with like-minded professionalorganisations like the International Confederationof Midwives (ICM). I was honoured to attend andspeak at its Triennial Congress in Toronto whereFIGO had four symposia sessions and adedicated booth. Building relationships and
With the Dutch Minister for Foreign Trade and Development Cooperation, Lilianne Ploumen, and the FIGO President, at theFamily Planning Summit in London (July 2017)
With Franka Cadée, the new ICM President (left), andoutgoing President, Frances Day-Stirk at ICM Toronto(June 2017) At the World Health Assembly, Geneva (May 2017)
FIGO welcomes Samia Khatun!FIGO extends a warm welcome to SamiaKhatun, Project Manager, Global SafeMotherhood project (maternity cover).
She has over seven years’ NGO researchand programme management experience,and has been most recently managing threeprojects (youth and women’s economicempowerment) at Plan International UK.
Samia has a Master’s in Political Economy ofDevelopment from the School of Oriental andAfrican Studies (SOAS), University of London,and she has practical internationaldevelopment experience, having spent timein rural Tanzania.
She also has five years’ experience operatingas a Trustee of a UK-based charitable fund.
She commented: ‘I am really excited to bejoining FIGO! As a women’s rights advocate Ihave always been interested in maternalhealth and am pleased to be able to expandmy knowledge of this, while utilising my skillsand experience.
‘FIGO has fantastic reach through itsMember Societies, which means greateroutcomes for global women’s health. I amlooking forward to working with colleaguesacross the Federation.’
4 In ter nat iona l Federat ion of Gynecology and Obstet r ics | September 2017
In April 2017, Latvian doctors congregated fora high profile medical Congress of obstetricsand gynecology in Monaco, under thepatronage of HSH Prince Albert II of Monaco.The Congress brought together updates andconsensus on topics of interest – includingmaternofoetal complications – especially withregard to cervical cancer in Latvia and the restof the world.
Professor Franco Borruto – an Honorary Memberof the Latvian Society – who was in attendance,explained the importance of work in this vital areaof women’s health: ‘Latvia – with about onemillion women over the age of 15 – has a veryhigh incidence rate of cervical cancer: 23 casesper 100,000, about six times higher than inneighbouring countries such as Finland. It isestimated that two women per week die fromcervical cancer in Latvia.’
According to Professor Silvia de Sanjosé(President of the International PapillomavirusSociety): ‘Monaco has a population of about14,000 women over 15 years of age, and accessto early detection is a common practice. TheMonaco authorities have deployed andsupervised all WHO recommendations forvaccination and screening. Wherever we are inthe world, vaccination is a key issue for HPVprevention. About 500,000 cases of cervicalcancer have already been prevented worldwidein the last 10 years by vaccination. We are stillawaiting 36 million cases of cervical cancer over
Prince Albert II of Monaco (centre), with Congress attendees. Immediate left, front row: Professor Franco Borruto, and Professor Bruno Carbonne
the course of life among women who live aroundthe world.
‘Experiences in different countries have shownthat the only programmes that succeed are inschool – for girls before 15 years of age, twodoses are sufficient. Immunisation reaches 80per cent in most countries.
‘Programmes need strong support from theauthorities. Only a strong official response, welldocumented and scientifically valid, can stop thisconflict (examples are the UK and Spain). WithHPV prevention, we have an important job to do.Women can be protected against HPV and wenow have the means to do so in a safe andeffective manner. We need to communicate this
good news to health professionals and thepublic, but especially to public health officials.
‘We have a problem, but now we have thesolution!’
Report and photographs courtesy of ProfessorFranco Borruto
Latvia meets Monaco!FIGO NEWS
FIGO Secretariatawarded SILVER by‘Investors in theEnvironment’!We started working with ‘Investorsin the Environment (IIE)’ towardsreducing our impact on theenvironment in early 2016. We arenow excited to announce that wehave been awarded the ‘Silver’level accreditation, scoring over90 per cent in this category!
We will now be putting all efforts into achieving the highest accreditation level – ‘Green’ – and to dothis, we will be concentrating on improving in the key areas of resource-tracking and measurement,as well as target-setting for our carbon footprint.
FIGO recognises the vital role that staff members have played insucceeding with this undertaking, and is immensely grateful for theircontribution and commitment.
We would also like to thank IIE for its guidance and advice!
Professor Borruto receiving an award from Professor DaceMatule (left), President of the Latvian Association ofGynaecologists and Obstetricians, and Professor Silvia deSanjosé (right), President of the InternationalPapillomavirus Society (IPVS)
FIGO’s Sustainability and Environmental Team
possible, as well as to the women themselveswho participated.
‘This drug is not a magic bullet and challengesremain in treating PPH, but it is an important toolthat can help prevent deaths and ensure morebabies grow up with a mother. We hope thoseworking in the O&G field will join us in sharing thefindings with their networks to ensure all medicalprofessionals across the globe are informed. Thiswill give women with PPH the greatestopportunity to benefit from the results.’
Future research will assess the bioavailability oftranexamic acid after alternative (non-intravenous) routes of administration, as thiscould potentially facilitate its use in primaryhealth-care settings.
Visit womantrial.lshtm.ac.uk for moreinformation and to join the WOMAN trial networkto receive further updates. You can also contactthe trial team at [email protected] and photographs courtesy of LSHTM
5In ter nat iona l Federat ion of Gynecology and Obstet r ics | September 2017
Post-partum haemorrhage (PPH) is the leadingcause of maternal death around the world. Thecondition is responsible for a third (30 per cent)of the 300,000 women who die in pregnancy orchildbirth globally each year.
Earlier this year, the results from a majorinternational clinical trial showed that a blood clotstabilising drug called tranexamic acid could bean important tool in tackling this major issue. TheWorld Maternal Antifibrinolytic (WOMAN) Trialinvolved 20,000 women in 193 hospitals across21 countries, co-ordinated by the Clinical TrialsUnit at the London School of Hygiene & TropicalMedicine. It found that tranexamic acid reduceddeath due to bleeding by 30 per cent if givenwithin three hours. There was also a significantreduction in the number of women who needed alaparotomy.
The effectiveness was seen across all causes ofbleeding, whether it was a caesarean or vaginaldelivery, but there was more significant benefit incases of uterine atony. There was no increase inarterial or venous thromboembolic complicationswith the use of the drug compared with placebo.
What makes these findings even more importantis that tranexamic acid is widely available and isrelatively inexpensive in most countries. It is alsoheat stable and is simple to administerintravenously in health care facilities, so thereshould be no reason why patients worldwidecannot receive the treatment if the will is thereamong clinicians and decision-making bodies.
Former FIGOPresident, Professor Sir SabaratnamArulkumaran, who wasChair of the WOMANTrial steeringcommittee, said: ‘Nowwe have this importantevidence, obstetriciansshould make use of theresults and ensure thatadequate stock oftranexamic acid isavailable and the drugis used early when
PPH occurs. Implementing this good practiceshould be the responsibility of both the nationalO&G societies and individual obstetricians. Usingthe drug as a frontline treatment should help usreduce maternal mortality due to PPH.’
Haleema Shakur,WOMAN Trial ProjectDirector and AssociateProfessor of ClinicalTrials at the LondonSchool of Hygiene &Tropical Medicine, said:‘Conducting a trial onthis scale was a majorfeat of collaborationand we are grateful toall those healthprofessionals aroundthe world who made it
Reducing deaths from post-partumhaemorrhage with a simple drug
Further steps towards human rights!‘The Women’s Health and Human Rights [WHHR] Committee met in Torino in July 2017 todiscuss work accomplished and future plans,’ said Professor Chiara Benedetto, CommitteeChair.
‘It was a pleasure to meet Dr DianaGalimberti, Chair of the FIGOWorking Group on Violence AgainstWomen, Dr Anita Makins, PPIUDInitiative Deputy Director, and DrFaysal El Kak, of the AmericanUniversity of Beirut. They sharedpersonal experiences, anddiscussed collaboration with theCommittee. Johan Vos, FIGO’sChief Executive, also attended,presenting vital contributions onFIGO’s commitment to fundraising.’
‘There will be a full report on ourexciting new work in the DecemberNewsletter!’
FIGO NEWS
IJGO impact factorsoars to 2.174!FIGO’s journal, the International Journal ofGynecology and Obstetrics (IJGO), hasseen its impact factor soar to 2.174, itshighest ever! The journal’s ranking has alsoincreased to 36/79 journals (up from47/80).
Abi Cantor, IJGO Managing Editor, said: ‘TheIJGO team is thrilled with the increase in ourimpact factor – it is a great achievement andmarks the efforts made by our editors,editorial office, publisher and FIGO to raisethe profile of the journal. The value is ameasure of how many times on average anIJGO article is cited one or two years afterpublication. Therefore, our new impact factorshows that IJGO content is being used afterpublication, whether to inform furtherresearch, practice, or policy.
‘Thank you to everyone who contributes tothe journal and reads its content. With yourcontinued help, IJGO will continue to grow!’
Abi Cantor, IJGO Managing Editor
Haleema Shakur
Professor Sir SabaratnamArulkumaran
A group photo at Sant’Anna Hospital, in front of the ‘Egg’ symbol of birthby Peppe Perone (Professor Benedetto left of centre, in white)
6 In ter nat iona l Federat ion of Gynecology and Obstet r ics | September 2017
FIGO ON TRAVELSFIGO highlights key projects at ICM 2017In June 2017, FIGO attended the 31stInternational Confederation of Midwives’ (ICM)Triennial Congress, held in Toronto, Canada,where we played a key role by holding foursessions dedicated to important topics inwomen’s health.
A dedicated session on a range of FIGO projectswas witnessed by a large audience of delegateson the first morning of the Congress.Presentations had a special focus – how FIGOworks with midwives around the world to tacklethe issues addressed by these projects. Thetopics covered in this session werehyperglycemia in pregnancy (presented by DrHema Divakar); violence against women(presented by Petra ten Hoope-Bender); unsafeabortion (presented by Professor Aníbal Faúndes)and FIGO’s post-partum IUD project (presentedby Winnie Shena and Martina Gitte). The sessionwas chaired by FIGO Chief Executive, Johan Vos.
Elsewhere, FIGO’s joint project with ICM –‘Helping Mothers Survive – Bleeding After Birth’ –was introduced by Joyce Lucy Atim, one of themidwives working on the research project inUganda.
The FIGO and Gynuity Health Projects’ expertpanel session took place on 20 June 2017.Drawing approximately 100–120 participants,this session introduced new interventions andmodels of PPH management that could helpexpand access to essential, life-saving care towomen across a variety of settings.
Presentations included: Nusrat Jehan – talkingabout new models of PPH management, usingmisoprostol at the community level in Pakistan;Rasha Dabash – presenting on the implicationsof research from India and Egypt comparingprimary prevention to secondary prevention/earlytreatment of PPH; Holly Anger – speaking aboutthe role of condom uterine-balloon tamponade inPPH management in Egypt, Senegal andUganda; and Dr Aguirre – discussing the role ofshock index in PPH diagnosis. The sessionfeatured FIGO’s new misoprostol only dosagechart. At the FIGO booth there was high demandfor the charts, causing us to run out of theprinted charts by the first day!
A joint IPAS/WHO/FIGO panel reviewed keyrecommendations on three key topics fromrecent WHO guidance related to pre-pregnancy:ensuring human rights in contraceptive care;expanding health worker roles in abortion andpost-abortion contraception; and eligibility criteriaand practice recommendations for contraceptive
care. Presenters covered practical information toimprove pre-pregnancy care and help midwivesprovide the full range of essential competenciesin midwifery practice.
FIGO also took the opportunity to promote itswork with an information booth in the exhibit hall.As well as featuring information and materialsabout FIGO projects, delegates also had theopportunity to speak with FIGO presenters, aswell as Chief Executive Johan Vos.
FIGO is committed to continuing and growing itswork with ICM and midwives, towards anintegrated approach to ensuring the good healthof women around the world.
Report courtesy of Samia Khatun, FIGO ProjectManager, Global Safe Motherhood Project, andMatthew Pretty, FIGO Project Co-ordinatorMartina Gitte presenting on FIGO’s post-partum IUD project
FIGO-Gynuity panel line-up
FIGO congratulates the SLCOG at its Golden JubileeFIGO was well represented at the Golden Jubilee of the Sri Lanka College of Obstetricians andGynaecologists (SLCOG) in early August, with attendance from the FIGO President and ChiefExecutive, and Past Presidents Professor Sir Sabaratnam Arulkumaran and Professor JohnSciarra.
FIGO President Professor Purandare said: ‘FIGO sincerely congratulates the SLCOG on its GoldenJubilee Congress. It is the premier body providing maternity care services for pregnant mothersand improving the adolescent health and health of post-reproductive women in the country, and itoccupies an absolutely pivotal position in the country’s healthcare system, ensuring that womenget the very best attention and treatment.
‘For such a landmark anniversary, it was only fitting that FIGO joined with AOFOG and SAFOG tomake it a truly international affair. In addition, several of FIGO’s valued Member Societies – ACOG,RCOG, RANZCOG, FOGSI and OGSM – were in attendance. A gathering of such calibre provideda fitting backdrop.
‘FIGO has a long history with the SLCOG – it is a greatly valued FIGO Member Society. We areproud to say that one of FIGO’s major initiatives, its project for “Institutionalising Post-Partum IUDServices”, was first piloted in Sri Lanka [now being reproduced in other countries], and aims toaddress the post-partum contraceptive needs of women by institutionalising the practice of offeringimmediate post-partum Intra-Uterine Device services (IUD) in hospital.
‘We hope that the SLCOG enjoyed its celebrations, which were most richly deserved. Wecongratulate its leaders on the organisation’s longevity and know that it will continue to worktirelessly on behalf of women and newborns. As we move further into the Sustainable DevelopmentGoal (SDG) era, this has never been more important.’
The opening ceremony with the President and Minister of Health of Sri Lanka
The FOGSI-FIGOconnection – focus onHyderabad 2017
Chief Executive Johan Vos giving his presentation
The FOGSI-FIGO 2017 InternationalCongress on Clinical Challenges inObstetrics and Gynaecology was held inHyderabad in early August 2017.
The FIGO President and Chief Executivewere in attendance.
Johan Vos said: ‘FIGO was well representedby its leadership at this important event – theworkshops, symposiums, panel discussionsand plenary sessions were of the higheststandard, and there was a strong focus oncontinuing to work towards the achievementof SDG 3: Ensure healthy lives and promotewellbeing for all at all ages.
‘As our stakeholders well know, FIGO isabsolutely committed to accelerating itsefforts and activities to reach SDG targets,especially in the area of safe motherhoodand newborn health.’
He ended: ‘FIGO thanks FOGSI, for itsgracious hospitality and its continuing closecollaboration with FIGO activities.’
7In ter nat iona l Federat ion of Gynecology and Obstet r ics | September 2017
FIGO Misoprostol Dosage Chart –new release!
Diary DatesEuropean Congress of the InternationalSociety for the Study of Hypertension inPregnancy6–9 September 2017, Berlin, Germanywww.euroisshp2017.com/programme/scientific-programme/27th World Congress on Ultrasound inObstetrics and Gynecology16–19 September 2017, Vienna, Austriawww.isuog.org/WorldCongress/2017Italian Society of Obstetrics andGynaecology 92nd National Congress 2017 8–11 October 2017, Rome, Italywww.sigo.it/news/sigo-20172nd International Symposium on ObstetricAnesthesia – Effect on Newborn and Mother 12–14 October 2017, Budapest, Hungarywww.obstanest.akcongress.com/index.php/symposium
14th Annual Congress of National IranianAssociation of Gynecologists & Obstetricians:‘Advances in Obstetrics and Gynecology’10–13 October 2017, Tehran, Iranwww.iranicog.ir/2nd Asia Pacific Symposium on Diabetes,Hypertension, Metabolic Syndrome andPregnancy 2017 (DIPAP 2017)27–28 October 2017, Shanghai, Chinawww.comtecmed.com/DIPAP/2017/RANZCOG Annual Scientific Meeting29 October–1 November 2017, Auckland, New Zealandwww.ranzcog2017asm.com.au/Latin American Federation of Societies ofObstetrics and Gynecology 2017 (FLASOG2017)5–9 November 2017, Cancun, Mexicowww.congresoflasog2017.org.mx/
Philippine Obstetrical and GynecologicalSociety Annual Convention and 71stAnniversary Celebration 2017 (POGS 2017)17–20 November 2017, Manila, Philippineswww.pogsannual.com
25th World Congress on Controversies inObstetrics, Gynecology & Infertility 2017(COGI 2017)30 November–2 December 2017, Vienna,Austriawww.cogi-congress.org/
28th German Congress for PerinatalMedicine 2017 (DGPM 2017)30 November–2 December 2017, Berlin,Germanywww.dgpm2017.com
French College of Obstetrics andGynaecology 41st National Congress 2017(CNGOF 2017)5–8 December 2017, Lille, Francewww.cngof-congres.fr/
IJGO apps are live!The IJGO app is now available from Wiley. Itbrings you a stimulating, high-impact mixtureof systematic reviews, RCTs, originalresearch, expert commentaries, women’shealth updates, communications and more.Enjoy an entirely new browsing and readingexperience, and keep up to date with themost important developments in obstetricsand gynecology research even faster:• Stay current with the latest articles through
Early View – updated almost daily• Full Screen Figure and Table Viewer• Be notified when a new issue is available• Download articles and issues for offline
perusal• Save your favourite articles for quick and
easy access• Share articles with colleagues or students
To download on either your Apple or Androiddevice, visit either of these pages:
https://play.google.com/store/apps/details?id=com.wiley.jas.ijgohttps://itunes.apple.com/us/app/international-journal-of-gynecology-obstetrics/id1189012643?ls=1&mt=8
The new FIGO 2017 misoprostol-only dosagechart has been released!
An update from the widely used 2012 chartdetailing recommended dosages of misoprostolwhen used by itself for a variety of gynecologicaland obstetrical indications has been revised andexpanded by an expert group and is nowavailable online:
Published as an open access specialcommunication with a commentary piece inIJGO: http://onlinelibrary.wiley.com/doi/10.1002/ijgo.12181/full
Also available as:• An A4 wall chart (for printing): English, French,
Spanish and Portuguese • Formatted into gestational wheels: English,
French, Spanish and Portuguese • Easy-to-access ‘credit cards’ for easy
reference: English, French, Spanish andPortuguese
Help us to disseminate these materials to allhealthcare workers involved in providing servicesfor women!: visit www.figo.org/pph orwww.figo.org/news/misoprostol-dosage-chart-new-release-0015613For more information, email [email protected]
FIGO RESOURCES
IJGO CALL FOR PAPERS: FIGO Congress Special Issue!To celebrate the XXII FIGO World Congress in Rio de Janeiro in October 2018, IJGO will bepublishing a special issue featuring papers focussing on Latin America.
We are actively calling for submissions of Clinical Articles, Review Articles and BriefCommunications that are relevant to Latin America, from all gynecology and obstetricsspecialties.
When preparing a paper for submission, please consult IJGO’s Author Guidelines, which areavailable via the IJGO website (www.wileyonlinelibrary.com/journal/ijgo). To submit a paper forthis special issue, please go to IJGO’s online system: www.editorialmanager.com/ijg/The cover letter should specify that the manuscript has been submitted in response to this call for papers. Please submit your manuscript and any supporting material to us by the deadline of 28 February, 2018, to be considered for the October 2018 special issue.
To find out more, please contact [email protected]
FIGO accepts no responsibility for the accuracy of the external event information. Inclusion of any event does notnecessarily mean that FIGO either endorses or supports it (unless otherwise stated)
